These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31686344)

  • 1. Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) in Colorectal Cancer is Associated with an Elderly, Frail Phenotype and Improved Recurrence-Free Survival.
    Watson MM; Kanani A; Lea D; Khajavi RB; Søreide JA; Kørner H; Hagland HR; Søreide K
    Ann Surg Oncol; 2020 Apr; 27(4):1058-1067. PubMed ID: 31686344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated microsatellite alterations at selected tetranucleotides in early-stage colorectal cancers with and without high-frequency microsatellite instability: same, same but different?
    Watson MM; Lea D; Rewcastle E; Hagland HR; Søreide K
    Cancer Med; 2016 Jul; 5(7):1580-7. PubMed ID: 27061136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
    Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
    Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) and Microsatellite Instability in Patients with Colorectal Cancer and Its Clinical Features.
    Lee HS; Park KU; Kim DW; Lhn MH; Kim WH; Seo AN; Chang HE; Nam SK; Lee SY; Oh HK; Kang SB
    Curr Mol Med; 2016; 16(9):829-839. PubMed ID: 27889996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is elevated microsatellite alterations at selected tetranucleotide repeats (EMAST)-negative/MSI-high colorectal cancer a distinct subtype of the disease?
    Park Y; Kim DW; Hong YJ; Park KU; Nam SK; Na HY; Lee HS; Kim MH; Oh HK; Kang SB
    J Surg Oncol; 2020 Dec; 122(7):1462-1469. PubMed ID: 32779222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer.
    Watson MM; Lea D; Gudlaugsson E; Skaland I; Hagland HR; Søreide K
    Cancer Immunol Immunother; 2020 Aug; 69(8):1627-1637. PubMed ID: 32314040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MSI-L/EMAST is a predictive biomarker for metastasis in colorectal cancer patients.
    Torshizi Esfahani A; Seyedna SY; Nazemalhosseini Mojarad E; Majd A; Asadzadeh Aghdaei H
    J Cell Physiol; 2019 Aug; 234(8):13128-13136. PubMed ID: 30549036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite instability at tetranucleotide repeats in sporadic colorectal cancer in Japan.
    Yamada K; Kanazawa S; Koike J; Sugiyama H; Xu C; Funahashi K; Boland CR; Koi M; Hemmi H
    Oncol Rep; 2010 Feb; 23(2):551-61. PubMed ID: 20043121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosticators of Long-Term Outcomes of TNM Stage II Colorectal Cancer: Molecular Patterns or Clinicopathological Features.
    Kuan TC; Chang SC; Lin JK; Lin TC; Yang SH; Jiang JK; Chen WS; Wang HS; Lan YT; Lin CC; Lin HH; Huang SC
    World J Surg; 2019 Dec; 43(12):3207-3215. PubMed ID: 31515570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EMAST status as a beneficial predictor of fluorouracil-based adjuvant chemotherapy for Stage II/III colorectal cancer.
    Mohammadpour S; Goodarzi HR; Jafarinia M; Porhoseingholi MA; Nazemalhosseini-Mojarad E
    J Cell Physiol; 2020 Apr; 235(4):3604-3611. PubMed ID: 31549400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMAST Type of Microsatellite Instability-A Distinct Entity or Blurred Overlap between Stable and MSI Tumors.
    Vuković Đerfi K; Salar A; Cacev T; Kapitanović S
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer.
    Burger M; Denzinger S; Hammerschmied CG; Tannapfel A; Obermann EC; Wieland WF; Hartmann A; Stoehr R
    J Mol Med (Berl); 2006 Oct; 84(10):833-41. PubMed ID: 16924473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.
    Kim CG; Ahn JB; Jung M; Beom SH; Kim C; Kim JH; Heo SJ; Park HS; Kim JH; Kim NK; Min BS; Kim H; Koom WS; Shin SJ
    Br J Cancer; 2016 Jun; 115(1):25-33. PubMed ID: 27228287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer.
    Haugen AC; Goel A; Yamada K; Marra G; Nguyen TP; Nagasaka T; Kanazawa S; Koike J; Kikuchi Y; Zhong X; Arita M; Shibuya K; Oshimura M; Hemmi H; Boland CR; Koi M
    Cancer Res; 2008 Oct; 68(20):8465-72. PubMed ID: 18922920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMAST is associated with a poor prognosis in microsatellite instable metastatic colorectal cancer.
    Venderbosch S; van Lent-van Vliet S; de Haan AF; Ligtenberg MJ; Goossens M; Punt CJ; Koopman M; Nagtegaal ID
    PLoS One; 2015; 10(4):e0124538. PubMed ID: 25884216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite instability, EMAST, and morphology associations with T cell infiltration in colorectal neoplasia.
    Lee SY; Miyai K; Han HS; Hwang DY; Seong MK; Chung H; Jung BH; Devaraj B; McGuire KL; Carethers JM
    Dig Dis Sci; 2012 Jan; 57(1):72-8. PubMed ID: 21773681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of carcinoembryonic antigen is influenced by microsatellite instability genotype and stage in locally advanced colorectal cancers.
    Søreide K; Søreide JA; Kørner H
    World J Surg; 2011 Apr; 35(4):888-94. PubMed ID: 21301835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer.
    Hamaya Y; Guarinos C; Tseng-Rogenski SS; Iwaizumi M; Das R; Jover R; Castells A; Llor X; Andreu M; Carethers JM
    PLoS One; 2015; 10(5):e0127591. PubMed ID: 25996601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between recurrent metastasis from stage II and III primary colorectal tumors and moderate microsatellite instability.
    Garcia M; Choi C; Kim HR; Daoud Y; Toiyama Y; Takahashi M; Goel A; Boland CR; Koi M
    Gastroenterology; 2012 Jul; 143(1):48-50.e1. PubMed ID: 22465427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring Microsatellite Instability (MSI) in Colorectal Cancer at Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST).
    Kurbatov V; Khan SA
    Ann Surg Oncol; 2020 Apr; 27(4):973-974. PubMed ID: 31788754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.